; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, Durable Medical Equipment, Prosthetics, Orthotics and Supplies (DMEPOS) Competitive Bidding Program (CBP) and Fee Schedule Amounts, and Technical Amendments To Correct Existing Regulations Related to the CBP for Certain DMEPOS published on November 14, 2018 (83 Fed. Reg. 56922 et seq.). (ii) Money to follow the patient The Secretary through notice and comment rulemaking shall implement a policy for any drug or biological that is not provided to the average patient that results in the amount by which the single payment amount is increased pursuant to this clause shall be paid only when a provider or renal dialysis facility has demonstrated that it has administered the drug or biological to a patient. . (f) New devices and other technologies As part of the promulgation of the annual rule for the Medicare end-stage renal disease prospective payment system under section 1881(b)(14) of the Social Security Act ( 42 U.S.C. 1395rr(b)(14) ) for calendar year 2021 and in consultation with stakeholders, the Secretary of Health and Human Services shall establish a process for identifying and determining appropriate payment amounts for incorporating new devices and technologies into the bundled payment under such system. III Improving the Accuracy and Transparency of End-Stage Renal Disease Quality Programs 301. Improve patient decision making and transparency by consolidating and modernizing quality programs (a) Measures Section 1881(h)(2) of the Social Security Act ( 42 U.S.C. 1395rr(h)(2) ) is amended— (1) by striking subparagraph (A) and inserting the following: (A) In general The measures specified under this paragraph with respect to the year involved shall be selected in consultation with stakeholders to promote improvement in beneficiary outcomes and shared decision-making with beneficiaries and their caregivers. When selecting